Baricitinib
Baricitinib is an orally active, selective inhibitor of JAK1 and JAK2. It is widely used in research for its immunomodulatory and anti-inflammatory properties, with applications in studying autoimmune diseases and hematological cancers in both in vitro and in vivo models.
Product Specifications
CAS Number
1187594-09-7
Product Name Alternative
Chk2, Baricitinib, INCB028050, INCB-028050, INCB 028050, Janus kinase, JAK1, JAK2, JAK3, JAK, inhibit, Inhibitor, LY3009104, LY-3009104, LY 3009104, Tyk2, TyrosineKinases, Tyrosine Kinases
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.00% (May vary between batches)
Solubility
H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 250 mg/mL (673.09 mM), Sonication is recommended.
Smiles
CCS (=O) (=O) N1CC (CC#N) (C1) n1cc (cn1) -c1[nH]cnc2nccc12
Molecular Formula
C16H17N7O2S
Molecular Weight
371.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
489431 100 µL
PROSC (Proline Synthase Co-transcribed Bacterial Homolog Protein, Proline Synthetase Co-transcribed Homolog (Bacterial) )
Sign In for Pricing
View Details 